World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
83
Citations
29357
World Ranking
15482
National Ranking
7809

Overview

Eric B. Haura is affiliated with the University of South Florida in the United States. Their research primarily focuses on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a significant concentration on Oncology and Molecular Biology. The scientist's work broadly covers Pulmonary and Respiratory Medicine, Cancer Research, and Immunology.

The main research topics associated with Eric B. Haura include:

  • Lung Cancer Treatments and Mutations
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Colorectal Cancer Treatments and Studies
  • Lung Cancer Research Studies
  • HER2/EGFR in Cancer Research
  • Peptidase Inhibition and Analysis

Eric B. Haura has a notable publication record in several venues, with frequent contributions to:

  • Cancer Research
  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Molecular Cancer Therapeutics
  • bioRxiv (Cold Spring Harbor Laboratory)

Key recent papers authored or co-authored by Eric B. Haura include:

  • Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study, 2021, Journal of Clinical Oncology
  • Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial, 2021, Nature Medicine
  • Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial, 2022, Nature Medicine
  • The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling, 2020, Immunity
  • Resistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures, 2020, Nature Communications

The scientist frequently collaborates with several colleagues, among whom the most frequent co-authors are:

  • John M. Koomen
  • Bin Fang
  • Eric A. Welsh
  • Uwe Rix
  • Theresa A. Boyle

Best Publications

  • Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs

    Mark G. Kris;Bruce E. Johnson;Lynne D. Berry;David J. Kwiatkowski

  • Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis

    Guilian Niu;Kenneth L Wright;Mei Huang;Lanxi Song

  • Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability

    Rosalie Sears;Faison Nuckolls;Eric Haura;Yoichi Taya

  • Src kinases as therapeutic targets for cancer

    Lori C. Kim;Lanxi Song;Eric B. Haura

  • Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes

    James D McKay;Rayjean J Hung;Younghun Han;Xuchen Zong

  • DNA Synthesis and Repair Genes RRM1 and ERCC1 in Lung Cancer

    Zhong Zheng;Tingan Chen;Xueli Li;Eric Haura

  • Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study

    Robert Carreras-Torres;Mattias Johansson;Philip C. Haycock;Kaitlin H. Wade

  • Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer

    Eric B Haura;James Turkson;Richard Jove

  • Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation.

    James Turkson;Declan Ryan;Joon S. Kim;Yi Zhang

  • Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer

    Peter S. Hammerman;Martin L. Sos;Alex H. Ramos;Chunxiao Xu

  • Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells.

    Lanxi Song;James Turkson;James G Karras;Richard Jove

  • Stat3 regulates genes common to both wound healing and cancer

    Daniel J Dauer;Bernadette Ferraro;Lanxi Song;Bin Yu

  • Amivantamab in EGFR exon 20 insertion-mutated non-small-cell lung cancer progressing on platinum chemotherapy: initial results from the CHRYSALIS phase I study

    Keunchil Park;Eric B Haura;Natasha B Leighl;Paul L R Mitchell

  • Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines

    Piyali Dasgupta;Wasia Rizwani;Smitha Pillai;Rebecca Kinkade

  • Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin

    Piyali Dasgupta;Rebecca Kinkade;Bharat Joshi;Christina DeCook

  • Nicotine induces cell proliferation by β-arrestin–mediated activation of Src and Rb–Raf-1 pathways

    Piyali Dasgupta;Shipra Rastogi;Smitha Pillai;Dalia Ordonez-Ercan

  • Identification of driver mutations in tumor specimens from 1,000 patients with lung adenocarcinoma: The NCI's Lung Cancer Mutation Consortium (LCMC).

    M. G. Kris;B. E. Johnson;D. J. Kwiatkowski;A. J. Iafrate

  • Novel peptidomimetic inhibitors of signal transducer and activator of transcription 3 dimerization and biological activity

    James Turkson;Joon S. Kim;Shumin Zhang;Jing Yuan

  • A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

    Eric B. Haura;Alejandro D. Ricart;Timothy G. Larson;Philip J. Stella

  • A chemical and phosphoproteomic characterization of dasatinib action in lung cancer.

    Jiannong Li;Uwe Rix;Bin Fang;Yun Bai

Frequent Co-Authors

John M. Koomen
John M. Koomen University of South Florida
Scott J. Antonia
Scott J. Antonia Duke University
Michael J. Schell
Michael J. Schell University of South Florida
Bruce E. Johnson
Bruce E. Johnson Harvard University
Amer A. Beg
Amer A. Beg University of South Florida
Paul A. Bunn
Paul A. Bunn University of Colorado Boulder
Alan B. Cantor
Alan B. Cantor Harvard University
David J. Kwiatkowski
David J. Kwiatkowski Brigham and Women's Hospital
Mark G. Kris
Mark G. Kris Memorial Sloan Kettering Cancer Center
Stig E. Bojesen
Stig E. Bojesen University of Copenhagen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in Medicine but seeking alternative or complementary routes, there are a variety of online degrees and career pathways in health care to consider. These options can provide flexible learning and open diverse roles beyond traditional medical school.

For those who want to enter nursing quickly, a 6 month lpn program lets you start a practical nursing career in as little as half a year. If you're passionate about mental health support, consider the shortest pmhnp program, which enables registered nurses to become psychiatric mental health nurse practitioners through accelerated study.

Not all medical careers require direct patient care. If you're drawn to organization and leadership, a health administration degree prepares you for roles managing hospitals, clinics, or health services. There are also options to pursue a graduate qualification affordably through the cheapest mha programs online.

These online programs offer flexibility, affordability, and valuable career prospects—helping you find the right fit in America’s dynamic healthcare landscape.

Best Scientists Citing Eric B. Haura

Trending Scientists